Haleos Labs (NSE:HALEOSLABS) Total Equity: ₹2,296 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:HALEOSLABS Haleos Labs Ltd NSE:HALEOSLABS
72 GF Score
Price ₹1,571.10
GF Value ₹1,084.27
Valuation Significantly Overvalued
! 10 Warning Signs
View Full Analysis

What is Haleos Labs Total Equity?

Haleos Labs NSE:HALEOSLABS -0.52% 72 Total Equity is ₹2,296 Mil as of Mar. 2026. GuruFocus rates NSE:HALEOSLABS with a GF Score™ of 72/100 and a GF Value™ of ₹1,084.27 (Significantly Overvalued). The stock has 10 warning signs investors should review.

Haleos Labs's total equity for the quarter that ended in Mar. 2026 was ₹2,296 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Haleos Labs Total Equity Historical Data

* Premium members only.

The historical data trend for Haleos Labs's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Haleos Labs Total Equity Chart

Haleos Labs Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Total Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,649.29 1,882.17 1,936.37 2,120.46 2,295.56

Haleos Labs Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2,120.46 0.00 2,224.76 0.00 2,295.56
NSE:HALEOSLABS
72GF Score
Haleos Labs Ltd NSE:HALEOSLABS
Total Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Haleos Labs Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Haleos Labs's Total Equity for the fiscal year that ended in Mar. 2026 is calculated as

Total Equity=Total Assets(Q: Mar. 2026 )-Total Liabilities(Q: Mar. 2026 )
=4544.084-2248.523
=2,296

Haleos Labs's Total Equity for the quarter that ended in Mar. 2026 is calculated as

Total Equity=Total Assets(Q: Mar. 2026 )-Total Liabilities(Q: Mar. 2026 )
=4544.084-2248.523
=2,296

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Equity →
What does a Total Equity of ₹2,296 Mil mean?
Haleos Labs (NSE:HALEOSLABS) has a Total Equity of ₹2,296 Mil as of Mar. 2026. The total amount of equity as record on a company's balance sheet. View historical data for Haleos Labs and its competitors.
Is Haleos Labs' Total Equity too high?
Haleos Labs' current Total Equity is ₹2,296 Mil. Overall, Haleos Labs has a GF Score™ of 72/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Haleos Labs' Total Equity compare to VRTX and REGN?
Haleos Labs' Total Equity of ₹2,296 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Equity for a Biotechnology company?
A good Total Equity depends on the Biotechnology industry context. However, Total Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Equity mean?
A high Total Equity can signal that a stock is expensive relative to its fundamentals. The total amount of equity as record on a company's balance sheet. View historical data for Haleos Labs and its competitors. Haleos Labs's current Total Equity is ₹2,296 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Haleos Labs stock overvalued right now?
Based on GuruFocus' analysis, Haleos Labs (NSE:HALEOSLABS) is currently considered Significantly Overvalued. The stock's GF Value™ is ₹1,084.27, compared to a current price of ₹1,571.10 — trading 44.9% above its estimated fair value. The current Total Equity is ₹2,296 Mil. Haleos Labs' overall GF Score™ is 72/100 with 10 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Equity calculated?
Total Equity is calculated from a company's financial statements. For Haleos Labs (NSE:HALEOSLABS), the current Total Equity is ₹2,296 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Haleos Labs (NSE:HALEOSLABS) Overvalued in 2026?

Based on GuruFocus' analysis, Haleos Labs stock appears to be overvalued. The current stock price of ₹1,571.10 is trading 44.9% above its estimated GF Value™ of ₹1,084.27. GuruFocus considers Haleos Labs to be Significantly Overvalued.

Key valuation signals for NSE:HALEOSLABS:

  • Total Equity: ₹2,296 Mil
  • GF Value™: ₹1,084.27 vs. price of ₹1,571.10 (44.9% above fair value)
  • GF Score™: 72/100 with 10 warning signs

No single metric tells the full story. See the NSE:HALEOSLABS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Haleos Labs Business Description

Other Exchanges 540679:India
Address Road Number 71, Plot Number 19 - III, Opposite Bharatiya Vidya Bhavan Public School, Jubilee Hills, Hyderabad, TG, IND, 500096
Haleos Labs Ltd is engaged in the Business of manufacturing Active Pharmaceutical Ingredients (APIs) and its intermediates and sells its products in India as well as exports. The group sells its products in India and also exports it to other countries. Some of its API products are used in therapy as an Antiulcer, Antifungal, Anti Obesity, Anesthesia, and others. The company has manufacturing facilities at Kazipally and Jeedimetla and its Research and Development center at Sanatnagar in Hyderabad.
72GF Score

Get the complete analysis for NSE:HALEOSLABS

Total Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹1,571.10
Price
₹1,084.27
GF Value